Dr. Carole Gresenz’s lab focuses on identifying early signs of Alzheimer's disease and related dementias using financial data. By analyzing credit data and combining it with Medicare records, the lab develops machine learning algorithms to predict the at-risk population for these conditions. The goal is to advance early diagnosis, which is crucial for better management and support of individuals facing these diseases.

Dr. Carlos F. Mendes De Leon's lab focuses on understanding the risk factors associated with Alzheimer's disease and related dementias (ADRD) in Nepal, a low-income country facing an aging population. The lab is building research capacity through training in data collection and analysis, and it aims to initiate a longitudinal study to evaluate the prevalence and determinants of ADRD, particularly in relation to international labor migration and the effects of armed conflict. This work not only seeks to uncover critical data for Nepal but also hopes to inform prevention strategies relevant to similar challenges faced in other low-resource countries.

Dr. Rebecca Riggins' lab focuses on understanding glioblastoma, one of the most aggressive brain cancers, and exploring innovative treatment strategies. The research investigates how a specific protein, ESRRB, interacts with other cellular components to influence tumor growth and mobility. By manipulating these interactions, the lab aims to develop new therapeutic approaches that could improve survival rates for glioblastoma patients.